Combining continuous glucose monitoring and insulin pumps to automatically tune the basal insulin infusion in diabetes therapy: a review
Сочетание непрерывного мониторинга глюкозы и инсулиновых помп для автоматической настройки базальной инфузии инсулина при лечении сахарного диабета: обзор
2019-03-29
SCID: 54.1/crr57h53
Discuss with AI
Type 1 diabetesautomated basal insulincontinuous glucose monitoringhypoglycemia preventioninsulin pumps
Figures from the paper
Abstract (AI)
For individuals affected by Type 1 diabetes (T1D), a chronic disease in which the pancreas does not produce any insulin, maintaining the blood glucose (BG) concentration as much as possible within the safety range (70-180 mg/dl) allows avoiding short- and long-term complications. The tuning of exogenous insulin infusion can be difficult, especially because of the inter- and intra-day variability of physiological and behavioral factors. Continuous glucose monitoring (CGM) sensors, which monitor glucose concentration in the subcutaneous tissue almost continuously, allowed improving the detection of critical hypo- and hyper-glycemic episodes. Moreover, their integration with insulin pumps for continuous subcutaneous insulin infusion allowed developing algorithms that automatically tune insulin dosing based on CGM measurements in order to mitigate the incidence of critical episodes. In this work, we aim at reviewing the literature on methods for CGM-based automatic attenuation or suspension of basal insulin with a focus on algorithms, their implementation in commercial devices and clinical evidence of their effectiveness and safety.
Key Findings
1
Continuous glucose monitoring improves detection of critical hypoglycemic and hyperglycemic episodes compared with intermittent glucose assessment.
2
Integrating CGM sensors with insulin pumps enables algorithms to automatically attenuate or suspend basal insulin delivery based on glucose measurements.
3
Maintaining blood glucose within the 70–180 mg/dl safety range is essential for reducing short- and long-term complications in Type 1 diabetes.
4
The review evaluates algorithmic approaches, implementation in commercial devices, and clinical evidence regarding their effectiveness and safety.
5
The reviewed methods address physiological and behavioral variability by dynamically adjusting basal insulin infusion to reduce critical glucose excursions.
Research Object
CGM-integrated insulin pump therapy for individuals with Type 1 diabetes
Research Subject
CGM-based automatic attenuation or suspension of basal insulin infusion and its clinical effectiveness and safety
Publication Details
Publication Date
2019-03-29
Journal
Publisher
ISSN
Cited by
52
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
In Silico Preclinical Trials: A Proof of Concept in Closed-Loop Control of Type 1 Diabetes2009
Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycemia in Patients With Type 1 Diabetes: A Randomized Clinical Trial2013
Wearable Continuous Glucose Monitoring Sensors: A Revolution in Diabetes Treatment2017
Hypoglycemia Prevention via Pump Attenuation and Red-Yellow-Green “Traffic” Lights Using Continuous Glucose Monitoring and Insulin Pump Data2010